Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today April 2
November 14, 2024 14:00
QPS Launches New Leukopak and Cell Therapy Products Facility
QPS Holdings, LLC announced today that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection a
November 14, 2024 11:10
Center for Disease Analysis Foundation Receives $7 Million Grant from the John C. Martin Foundation to Support the Polaris Observatory
The Center for Disease Analysis (CDA) Foundation is pleased to announce receipt of a $7 million grant from the John C. Martin Foundation to sustain and expand the Polaris Observatory until the end of
November 14, 2024 10:30
Novotech Releases In-Depth Report on Cervical Cancer: Addressing a Global Health Challenge
Novotech, the global full-service clinical Contract Research Organization (CRO), has released a new report, Cervical Cancer - Global Clinical Trial Landscape (https://cts.businesswire.com/ct/CT?id=sma
November 13, 2024 15:50
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical Data and Biometric Solutions for Clinical Trials
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.medidata.com%2Fen%2F&esheet=54151261&newsitemid=20241112963841&lan=en-US&anchor=Medidata&index=1&md5=1aed735279447556547
November 13, 2024 11:35
AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States
AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint by the end of 2026. This includes $2 billion
November 13, 2024 10:55
Biocytogen Announces IDEAYA’s Nomination of Development Candidate IDE034, a Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC and Option Exercise
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that IDEAYA Biosciences, Inc.
November 13, 2024 08:58
Novotech and Biostar Establish Strategic Partnership Following Biostar’s HKEX Listing
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 12, 2024 15:38
Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial
Merck, a leading science and technology company, today announced that the Phase III MANEUVER trial of pimicotinib, an investigational medicine being developed by Abbisko Therapeutics Co., Ltd., met it
November 12, 2024 10:30
Huonslab reinforces HyDIFFUZE™ (Recombinant human hyaluronidase PH20) Intellectual Property by completing the US and EU Examination Request under PCT application.
Huonslab, Co. Ltd. (https://huonslab.com/layout/eng/home.php?go=main&) S. Korea, a subsidiary of Huons Global (https://huonsglobal.com/eng/home.php) (KOSDAQ:084110) and a global leader in recombinant
November 12, 2024 09:45
Novotech Recognized for Excellence in Business Expansion, Innovation, and Marketing at the 2024 Clinical Trials Arena Excellence Awards
Novotech, the global full-service clinical Contract Research Organization (CRO), has received multiple awards in the 2024 Clinical Trials Arena Excellence Awards, recognizing the achievements of our p
November 08, 2024 16:10
Huons Speeds up Biopharmaceutical Development with Human-Derived Hyaluronidase and Expands Bio-Pharma Business by Acquiring Stake in PanGen
Huons Co., Ltd. (https://www.huons.com/eng/home.php?go=main)(KRX:243070) (Co-CEOs : Song Soo-young and Yoon Sang-bae) announced on November 5 that it has decided to acquire 2,647,378 shares of PanGen
November 08, 2024 15:15
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”, or the “Company”, or “SBC”), a global owner, operator and provider of management services and products to cosmetic treatment cente
November 07, 2024 10:15
BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Brut
November 06, 2024 15:10
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award
Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, and Response Plus Medical Services (RPM), the largest pre-hospital care and emergency medical services provider in t
November 05, 2024 16:15
Parse Biosciences Launches Evercode Low Input Fixation for Cells and Nuclei
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the launch and availability of Evercode™ Low Input Fixation kits (https://cts.busines
November 05, 2024 15:10
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Japan-based Global Specialty Pharmaceutical Company Kyowa Kirin Co., Ltd. (President and CEO: Masashi Miyamoto.) (TOKYO:4151) today announced that Masashi Miyamoto, Ph.D. will take the role of Chairma
November 04, 2024 16:55
Celebrating 25 Years of Sculptra®: New Data and Recent Approval in China Cements Galderma’s Leadership in Regenerative Biostimulation
This month marks the 25th anniversary of the approval of Sculptra®, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation.[1-5,10-16]Sculptra works with
November 03, 2024 11:30
Medidata Launches Bundled Solutions to Support Oncology and Vaccine Trials, Accelerating Study Design and Execution
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.medidata.com&esheet=54145051&newsitemid=20241031324962&lan=en-US&anchor=Medidata&index=1&md5=ae204c6a0f9fac4adb7ac338e882
November 03, 2024 10:45
Neutrogena® Launches Breakthrough Collaboration with Two of World’s Most Recognizable Dermatologists
Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced its Neutrogena® brand is taking dermatological beauty to the next level by establ
November 03, 2024 10:30
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54142153&newsitemid=20241030235134&lan=en-US&anc
November 01, 2024 16:10
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
ELIQUENT Life Sciences (ELIQUENT), a global regulatory consulting firm, today announced the appointment of Rob Wojciechowski as Managing Director of the Consulting Practice across Europe and the Asia-
November 01, 2024 14:30
Medidata and Cogstate Strike Strategic Partnership Transforming Clinical Trials in Neurology with Clinical Outcome Assessment (eCOA) and Clinician Solutions Powered by AI and Advanced Analytics
Medidata (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fmedidata.com&esheet=54142421&newsitemid=20241029570790&lan=en-US&anchor=Medidata&index=1&md5=0177f87e5f8ba1d95a947b55a8ead5ee
October 31, 2024 09:13
US FDA Accepts Biologics License Application (BLA) for HLX14, Biosimilar Candidate of PROLIA/XGEVA (denosumab)
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the US Food and Drug Administration (FDA) has accepted the Biologic License Application (BLA) for HLX14, an investigatio
October 30, 2024 14:40
Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54143515&newsitemid=20241029413584&lan=en-US&anchor=Parse+Biosciences&index=1&md
October 30, 2024 14:25
Naobios and Sumagen Successfully Optimize HIV Vaccine Candidate for Industrial Production
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-based products, and Sumagen Canada Inc (Sumagen),
«
4
5
6
7
8
»
25 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice